port-wine stain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 0-65 years; 2) healthy patient; 3) Having not accepted any treatment before; 4) Having not accepted any oral drugs which will affect blood clotting; 5) Ability and willingness to sign an inform consent form after fully understanding the therapeutic and follow-up strategies.
Exclusion criteria
Exclusion criteria: 1) Insufficient pulmonary functions and hepatorenal functions; 2) Patients with fever or WBC less than 2500 / cubic millimeter; 3) The combined use of other drugs which will affect blood clotting; 4) Serious underlying systemic disease requiring treatment until illness either completes therapy or achieves clinical stablility on therapy for at least 6 months before enrolled the study. The systemic diseases include insufficient pulmonary functions (COPD, pneumonia, pulmonary fibrosis and asthma), insufficient cardiac and hepatorenal functions, infection, hemorrhagic tendency, immunologic disease(SLE, urticaria, HIV); 5) Patient who had laser treatment before.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy; | — |
Countries
China
Contacts
Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine